Conmed (CNMD) Invested Capital (2016 - 2025)
Historic Invested Capital for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $1.0 billion.
- Conmed's Invested Capital fell 400.27% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year decrease of 400.27%. This contributed to the annual value of $1.0 billion for FY2025, which is 400.27% down from last year.
- Conmed's Invested Capital amounted to $1.0 billion in Q4 2025, which was down 400.27% from $1.1 billion recorded in Q3 2025.
- In the past 5 years, Conmed's Invested Capital ranged from a high of $1.1 billion in Q2 2025 and a low of $806.8 million during Q2 2022
- For the 5-year period, Conmed's Invested Capital averaged around $975.9 million, with its median value being $980.7 million (2021).
- In the last 5 years, Conmed's Invested Capital tumbled by 1738.83% in 2022 and then skyrocketed by 1356.44% in 2024.
- Conmed's Invested Capital (Quarter) stood at $1.0 billion in 2021, then decreased by 13.07% to $879.4 million in 2022, then grew by 7.83% to $948.3 million in 2023, then increased by 13.56% to $1.1 billion in 2024, then fell by 4.0% to $1.0 billion in 2025.
- Its Invested Capital was $1.0 billion in Q4 2025, compared to $1.1 billion in Q3 2025 and $1.1 billion in Q2 2025.